In a recent episode of our Molecular Imaging in Focus series, Christopher Rowe, MD, BMBS, FRACP, FAANMS, discussed pertinent phase 3 study findings for florquinitau F 18 that were presented at the recent Clinical Trials on Alzheimer’s Disease conference.
The a2z-Omni-Triage software reportedly facilitates adjunctive triage for a number of findings including pneumothorax, coccygeal fracture, bowel perforation and moderate or severe hydronephrosis.
In a recent interview, Phillip Koo, MD, shared his thoughts on the impact of AI in radiology and nuclear medicine, the emergence and potential with theranostics, and how patient empowerment has changed radiology reporting.
In a recent interview at the HLTH USA conference, Maria Ansari, MD, FACC, shared her perspective on the ongoing evolution of AI in health care and how it can facilitate the increasing emphasis on value-based care.